rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-6-4
|
pubmed:abstractText |
Different studies have demonstrated that a small proportion of healthy individuals receiving the hepatitis B (HB) vaccine do not produce protective levels of anti-HB antibody, a phenomenon which could be linked to certain human leukocyte antigen (HLA) class-II alleles or haplotypes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1735-1383
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
92-9
|
pubmed:meshHeading |
pubmed-meshheading:18523354-Adult,
pubmed-meshheading:18523354-Alleles,
pubmed-meshheading:18523354-Female,
pubmed-meshheading:18523354-HLA-DQ Antigens,
pubmed-meshheading:18523354-HLA-DR Antigens,
pubmed-meshheading:18523354-Haplotypes,
pubmed-meshheading:18523354-Health,
pubmed-meshheading:18523354-Hepatitis B Vaccines,
pubmed-meshheading:18523354-Humans,
pubmed-meshheading:18523354-Male,
pubmed-meshheading:18523354-Vaccines, Synthetic
|
pubmed:year |
2008
|
pubmed:articleTitle |
HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine.
|
pubmed:affiliation |
National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|